Mutational analysis of a transforming growth factor-β receptor binding site

Growth Factors

Volumn 15, Issue 3, 1998, Pages 231-242

  Burmester, James K ^a   Wen Qian, S U ^b   Ohlsen, Dennis ^a   Phan, Sonja ^a   Sporn, Michael B ^c   Roberts, Anita B ^d  

^a MARSHFIELD CLINIC   (United States)

^b Advanced Genetic Technologies   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Colon cancer; Growth inhibition; Isoform; Protein structure

Indexed keywords

CHIMERIC PROTEIN; MUTANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; CELL GROWTH; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RECEPTOR BINDING;

ANIMALIA;

EID: 0345215161     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977199809002119     Document Type: Article

References (51)

1. Archer, S. J., Bax, A., Roberts, A. B., Sporn, M. B., Ogawa, Y., Piez, K. A., Weatherbee, J. A., Tsang, M. L., Lucas, R., Zheng, B. L., Wenker, J. and Torchia, D. A. (1993a) Transforming growth factor ß1: NMR signal assignments of the recombinant protein expressed and isotopically enriched using Chinese hamster ovary cells. Biochemistry, 32(4), 1152-1163.
2. Archer, S. J., Bax, A., Roberts, A. B., Sporn, M. B., Ogawa, Y., Piez, K. A., Weatherbee, J. A., Tsang, M. L., Lucas, R., Zheng, B. L., Wenker, J. and Torchia, D. A. (1993b) Transforming growth factor ß1: Secondary structure as determined by heteronuclear magnetic resonance spectroscopy. Biochemistry, 32(4), 1164-1171.
3. Beck, L. S., Chen, T. L., Hirabayashi, S. E., Deguzman, L., Lee, W. P., McFatridge, L. L., Xu, Y., Bates, R. L. and Ammann, A. J. (1990) Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-ß1. Growth Factors, 2(4), 273-282.
4. Brunner, A. M., Marquard, H., Malacko, A. R., Lioubin, M. N. and Purchio, A. F. (1989) Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor ß1 precursor. Expression and characterization of mutant proteins. J. Biol Chem., 264(23), 13660-13664.
5. Burmester, J. K., Qian, S. W., Roberts, A. B., Huang, A., Amatayakul-Chantler, S., Suardet, L., Odartchenko, N., Madri, J. A. and Sporn, M. B. (1993) Characterization of distinct functional domains of transforming growth factor-ß. Proc. Natl. Acad. Sci. USA, 90(18), 8628-8632.
6. Castilla, A., Prieto, J. and Fausto, N. (1991) Transforming growth factors ß1 and α in chronic liver disease. Effects of interferon alfa therapy. N. Engl. J. Med., 324(14), 933-940.
7. Cheifetz, S., Hernandez, H., Laiho, M., ten Dijke, P., Iwata, K. K. and Massagué, J. (1990) Distinct transforming growth factor-ß (TGF-ß) receptor subsets as determinants of cellular responsiveness to three TGF-ß isoforms. J. Biol. Chem., 265(33), 20533-20538.
8. Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeus, C., Massagué, J. and Letarte, M. (1992) Endoglin is a component of the transforming growth factor-ß receptor system in human endothelial cells. J. Biol. Chem., 267(27), 19027-19030.
9. Chen, R. H., Ebner, R. and Derynck, R. (1993) Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-ß activities. Science, 260(5112), 1335-1338.
10. Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B. and Sporn, M. B. (1989) Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-ß1 and TGF-ß2) secreted by cells in culture. J. Cell. Physiol., 138(1), 79-86.
11. Daopin, S., Piez, K. A., Ogawa, Y. and Davies, D. R. (1992) Crystal structure of transforming growth factor-ß2: An unusual fold for the superfamily. Science, 257(5068), 369-373.
12. Frolik, C. A., Wakefield, L. M., Smith, D. M. and Sporn, M. B. (1984) Characterization of a membrane receptor for transforming growth factor-ß in normal rat kidney fibroblasts. J. Biol. Chem., 259(17), 10995-11000.
13. Geiser, A. G., Burmester, J. K., Webbink, R., Roberts, A. B. and Sporn, M. B. (1992) Inhibition of growth by transforming growth factor-ß following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. J. Biol. Chem., 267(4), 2588-2593.
14. Hahn, S. A., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Schutte, M., Rozenblum, E., Seymour, A. B., Weinstein, C. L., Yeo, C. J., Hruban, R. H. and Kern, S. E. (1996) Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res., 56(3), 490-494.
15. Hanks, S. K., Armour, R., Baldwin, J. H., Maldonado, F., Spiess, J. and Holley, R. W. (1988) Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc. Natl. Acad. Sci. USA, 85(1), 79-82.
16. Higuchi, R., Krummel, B. and Saiki, R. K. (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res., 16(15), 7351-7367.
17. Hinck, A. P., Archer, S. J., Qian, S. W., Roberts, A. B., Sporn, M. B., Weatherbee, J. A., Tsang, M. L.-S., Lucas, R., Zheng, B.-L., Wenker, J. and Torchia, D. A. (1996) Transforming growth factor ß1: Three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor ß2. Biochemistry, 35(26), 8517-8534.
18. Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A. and Border, W. A. (1996) Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. Med., 2(4), 418-423.
19. Khalil, N. and Greenberg, A. H. (1991) The role of TGF-ß in pulmonary fibrosis. Ciba Found. Symp., 157, 194-207.
20. Koli, K. M. and Arteaga, C. L. (1997) Predominant cytosolic localization of type II transforming growth factor-ß receptors in human breast carcinoma cells. Cancer Res., 57, 970-977.
21. Kondaiah, P., Van Obberghen-Schilling, E., Ludwig, R. L., Dhar, R., Sporn, M. B. and Roberts, A. B. (1988) cDNA cloning of porcine transforming growth factor-ß1 mRNAs. Evidence for alternate splicing and polyadenylation. J. Biol. Chem., 263(34), 18313-18317.
22. Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A. and Thorbecke, G. J. (1991) Protective effect of transforming growth factor ß1 on experimental autoimmune diseases in mice. Proc, Natl. Acad. Sci. USA, 88(7), 2918-2921.
23. Lastres, P., Letamendía, A., Zhang, H., Rius, C., Almendro, N., Raab, U., López, L. A., Langa, C., Fabra, A., Letarte, M. and Bernabéu, C. (1996) Endoglin modulates cellular responses to TGF-ß1. J. Cell Biol., 133(5), 1109-1121.
24. Lee, S. J. and Nathans, D. (1988) Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J. Biol. Chem., 263(7), 3521-3527.
25. Lin, H. Y., Moustakas, A., Knaus, P., Wells, R. G., Henis, Y. I. and Lodish, H. F. (1995) The soluble exoplasmic domain of the type II transforming growth factor (TGF)-ß receptor. J Biol Chem., 270(6), 2747-2754.
26. Lin, H. Y., Wang, X. F., Ng-Eaton, E., Weinberg, R. A. and Lodish, H. F. (1992) Expression cloning of the TGF-ß type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68, 775-785.
27. Lopez-Casillas, F., Wrana, J. L. and Massagué, J. (1993) Betaglycans presents ligand to the TGF-ß signaling receptor. Cell, 73(7), 1435-1444.
28. MacKay, K., Robbins, A. R., Bruce, M. D. and Danielpour, D. (1990) Identification of disulfide-linked transforming growth factor-ß1-specific binding proteins in rat glomeruli. J. Biol. Chem., 265(16), 9351-9356.
29. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L.-Z., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. and Willson, J. K. V. (1995) Inactivation of the type II TGF-ß receptor in colon cancer cells with microsatellite instability. Science, 268(5215), 1336-1338.
30. Massagué, J. (1990) The transforming growth factor-ß family. Annu. Rev. Cell. Biol., 6, 597-641.
31. Massagué, J. and Like, B. (1985) Cellular receptors for type ß transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem., 260(5), 2636-2645.
32. McAllister, K. A.,Grogg, K. M., Johnson, D. W.,Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrell, J., McCormick, M. K., Pericak-Vance, M. A., Heutink, P., Oostra, B. A., Haitjema, T., Westerman, C. J. J.,Porteous, M. E., Guttmacher, A. E., Letarte, M. and Marchuk, D. A. (1994) Endoglin, a TGF-ß binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet., 8(4), 345-351.
33. McAllister, K. A., Baldwin, M. A., Thukkani, A. K., Gallione, C. J., Berg, J. N., Porteous, M. E., Guttmacher, A. E. and Marchuk, D. A. (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum. Mol. Genet, 4(10), 1983-1984.
34. Mittl, P. R. E., Priestle, J. P., Cox, D. A., McMaster, G., Cerletti, N. and Grütter, M. G. (1996) The crystal structure of TGF-ß3 and comparison to TGF-ß2: Implications for receptor binding. Protein Sci., 5, 1261-1271.
35. Myeroff, L. L., Parsons, R., Kim, S.-J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y.-J., Lee, H. Y., Park, J.-G., Lynch, H. T., Roberts, A. B., Vogelstein, B. and Markowitz, S. D. (1995) A transforming growth factor ß receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55(23), 5545-5547.
36. Peltonen, J., Hsiao, L. L., Jaakkola, S., Sollberg, S., Aumailley, M., Timpl, R., Chu, M.-L. and Uitto, J. (1991) Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-ß1 mRNA. J. Invest. Dermatol., 97(12), 240-248.
37. Postlethwaite, A. E. and Seyer, J. M. (1995) Identification of a chemotactic epitope in human transforming growth factorß1 spanning amino acid residues 358-374. J. Cell Physiol., 164(13), 587-592.
38. Qian, S. W.,Burmester, J. K., Merwin, J. R., Madri, J. A., Sporn, M. B. and Roberts, A. B. (1992) Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor-ß on endothelial cells. Proc. Natl. Acad. Sci. USA, 89(14), 6290-6294.
39. Qian, S. W., Burmester, J. K., Sun, P. D., Huang, A., Ohlsen, D. J., Suardet, L., Flanders, K. C., Davies, D., Roberts, A. B. and Sporn, M. B. (1994) Characterization of mutated transforming growth factor-ßs which possess unique biological properties. Biochemistry, 33(40), 12298-12304.
40. Qian, S. W., Burmester, J. K., Tsang, M. L. S.,Weatherbee, J. A., Hinck, A. P., Ohlsen, D. J., Sporn, M. B. and Roberts, A. B. (1996) Binding affinity of transforming growth factor-ß to the type II receptor is determined by the C-terminal region of the molecule. J Biol Chem., 271(48), 30656-30662.
41. Roberts, A. B. and Sporn, M. B. (eds.) (1990) The transforming growth factor-βs. Peptide Growth Factors and Their Receptors. M. B. Sporn and A. B. Roberts, eds., Handbook of Experimental Pharmacology, Springer:Berlin, Heidelberg, 1, Chapter 8, pp 419-472.
42. Rodriguez, C., Chen, F., Weinberg, R. A. and Lodish, H. F. (1995) Cooperative binding of transforming growth factor (TGF)-ß2 to the types I and II TGF-ß receptors. J. Biol. Chem., 270(7), 15919-15922.
43. Schlunegger, M. P. and Grutter, M. G. (1992) An unusual feature revealed by the crystal structure at 2.2Å resolution of human transforming growth factor-ß2. Nature, 358(6385), 430-434.
44. Sonis, S. T., Lindquist, L., Van Vugt, A., Stewart, A. A., Stam, K., Qu, G.-Y., Iwata, K. K. and Haley, J. D. (1994) Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor ß3. Cancer Res., 54(5), 1135-1138.
45. Sporn, M. B. and Roberts, A. B. (1990) TGF-ß: Problems and prospects. Cell Regul., 1(12), 875-882.
46. Suardet, L., Gaide, A.-C., Calmes, J.-M., Sordat, B., Givel, J.-C., Eliason, J. F. and Odartchenko, N. (1992) Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors ß1 and ß2. Cancer Res., 52(13), 3705-3712.
47. Wang, J., Sun, L.-Z., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V. and Brattain, M. G. (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270(37), 22044-22049.
48. Webb, D. J., Atkins, T. L., Crookston, K. P., Burmester, J. K., Qian, S. W. and Gonias, S. L. (1994) Transforming growth factor-ß isoform 2-specific high affinity binding to native α2-macroglobulin. Chimeras identify a sequence that determines affinity for native but not activated α2-macroglobulin. J. Biol. Chem., 269(48), 30402-30406.
49. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F. and Massagué, J. (1992) TGF-ß signals through a heteromeric protein kinase receptor complex. Cell, 71(6), 1003-1014.
50. Yamashita, H., ten Dijke, P., Franzen, P., Miyazono, K. and Heldin, C. H. (1994) Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factorß. J. Biol Chem., 269(31), 20171-20178.
51. Zhou, G.-H. K., Sechrist, G. L., Periyasamy, S., Brattain, M. G. and Mulder, K. M. (1995) Transforming growth factor ß isoform-specific differences in interactions with type I and II transforming growth factor ß receptors. Cancer Res., 55(10), 2056-2062.